Paris, France, March 1, 2017 – Medicen Paris Region, Europe’s leading healthcare cluster, today announcesthat its first ever two-day France-India Healthcare Summit is taking place today and tomorrow at the Biocitech biopark in Romainville, France. The summit is aimed at exploring opportunities, sharing best practice and jointly evaluating challenges that lay ahead for both countries.

With differing demographics, funding and financing systems, the healthcare sectors of India and France face different sets of challenges in the years to come. However, there are three key areas that can be explored jointly, on which the summit will focus, including:

  • Enabling better access to diagnostics and treatments in remote areas
  • Reducing the cost of medical care by streamlining organisations, standardisation and systematic reengineering
  • Efficient innovation in products, protocols and processes to tackle challenges of the future

The summit will bring together six high-level keynote speakers from India and France, including Pr. K. Vijayraghavan, secretary of the department of biotechnology, government of India and chair of the funding agency for SMEs, BIRAC – the Biotechnology Industry Research Assistance Council. It will feature four roundtable discussions on key areas such as medical devices, rare diseases, e-health and personalized medicine as well as innovative management opportunities.

Over the two days, attendees can also hear experts, healthcare practitioners, researchers, members of both governments and private companies share their experience in doing business in the French and Indian healthcare sectors, and participate in dedicated networking sessions. Start-ups will have the opportunity to display in the Start-up corner, and to pitch to investors and potential partners. Twenty investment funds & VCs will also attend the event.

“We believe that future challenges awaiting healthcare systems in both India and France can be tackled successfully if we join forces and share our insight and experience,” said Christian Lajoux, president of Medicen Paris Region. “We are very much looking forward to seeing the best experts from both countries addressing issues and finding solutions at this very first France-India Healthcare Summit. This is a great start for our future cooperation in the healthcare sector.”

“I’m looking forward to this inspiring event organized by the Medicen cluster. It will allow us to strengthen our existing bilateral economic relations and foster new partnerships and strategic alliances in the healthcare sector,” said H.E. Mohan Kumar, India’s ambassador in France. “We are also delighted that India can host the second edition of the event next year, where ‘La French Tech’ and the Indian healthcare sector will be able to continue to explore further cooperation opportunities.”

For further information on speakers and schedule, please visit

About Medicen Paris Region 

Medicen Paris Region is a competitiveness cluster for innovative health technologies, with national and international scope. With nearly 300 companies, research centers, universities, hospitals and local authorities as members, it aims to position the Paris region as Europe’s leading health cluster. It focuses on five strategic areas: biological diagnostics, diagnostic and interventional imaging, regenerative medicine and biomaterials, digital health and translational medicine. In close collaboration with local, regional and national healthcare innovation players, Medicen Paris Region aims to:

  • Foster the emergence, development and funding of certified collaborative projects in the healthcare sector, in order to create economic value and jobs
  • Increase the international development of innovative startups and SMEs
  • Strengthen the attractiveness of the Paris region, which represents more than 50% of life sciences activity in France

Since the creation of the cluster in 2005, 57 innovative products have been launched in the imaging, medical devices and biological tools sectors. The cluster has certified 289 projects. They received funding from the French government (French Inter-Ministry Fund FUI, Structuring Projects fund), the public investment bank Bpifrance, the National Research Agency, the European Regional Development Fund, the Investments for the Future program and/or local authorities, and the Paris region. Total investment is close to €1.2 billion and €533 million of public aid.